March 10, 2010 at 09:21 AM EST
SAFE-BioPharma Association Issues Interactive Online Progress Report

SAFE-BioPharma Association, the non-profit association that manages the SAFE-BioPharma® digital identity and digital signature standard, has issued its first interactive annual report. The report is available online at http://www.safe-biopharma.org/annualreport.

The document summarizes the growing adoption of the SAFE-BioPharma standard within the biopharmaceutical industry and its potential for the US healthcare arena. Highlights include the following:

  • How Pfizer scientists used SAFE-BioPharma digital signatures more than 1 million times and saved 16+ tons of paper
  • Why lower association membership fees are attracting smaller biopharma companies, clinical research organizations, diagnostics companies and others
  • The introduction of a new 15-minute online procedure to verify the identity of an applicant for a SAFE-BioPharma digital credential
  • Growing acceptance of the SAFE-BioPharma standard among global regulatory agencies

About SAFE-BioPharma Association (www.safe-biopharma.org) SAFE-BioPharma Association provides users with a secure, enforceable, and regulatory compliant way to verify identities of parties involved in electronic transactions and to apply digital signatures to electronic documents.

The Association’s members include:

SAFE-BioPharma® is a trademark of SAFE-BioPharma Association. Any use of this trademark requires approval from SAFE-BioPharma Association.

Contacts:

SAFE-BioPharma Association
Jon Weisberg
M 801-860-9977
O 801-359-9977
Jon.weisberg@safe-biopharma.org
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here